Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids

Chest

Volumn 126, Issue 2, 2004, Pages 389-393

  Barczyk, Adam ^a   Sozañska, Ewa ^a   Trzaska, Marzena ^a   Pierzchała, Władysław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

COPD; Induced sputum; Myeloperoxidase; Oral glucocorticoids treatment

Indexed keywords

BIOLOGICAL MARKER; CHEMOATTRACTANT; GLUCOCORTICOID; INTERLEUKIN 8; MYELOPEROXIDASE; PREDNISONE;

ADULT; AGED; AIRWAY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FATIGUE; FEMALE; FEVER; HEALTH STATUS; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG FUNCTION TEST; MALAISE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; SPUTUM ANALYSIS; SPUTUM EXAMINATION; SUPERNATANT; TACHYCARDIA; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 4143087099     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.2.389     Document Type: Article

References (26)

1. Paggiaro PL, Dahle R, Bakran I, et al. Multicentre, randomised, placebo-controlled trial of inhaled fluticasone propionate in subjects with chronic obstructive pulmonary disease: international COPD study group. Lancet 1998; 351:773-780
2. Burge PS, Calverley PM, Jones PW, et al. Randomised, double-blind, placebo controlled study of fluticasone propionate in subjects with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320:1297-1303
3. Thompson WH, Nielson CP, Carvalho P, et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154:407-412
4. Davies L, Angus RM, Calverley PMA. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354:456-460
5. Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbation of chronic obstructive pulmonary disease: Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999; 340:1941-1947
6. Mitchell DM, Gildeh P, Rehahm M, et al. Effects of prednisolone in chronic airflow limitation. Lancet 1984; 2:193-195
7. Nisar M, Walshaw MJ, Earis JE, et al. Assessment of airway reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax 1990; 45:190-194
8. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534
9. Pavord ID, Brightling CE, Woltmann G, et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353:2213-2214
10. Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548
11. Confalonieri M, Mainardi E, Della Porta R, et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53:583-585
12. Culpitt SV, Maziak W, Loulddis S, et al. Effect of high dose inhaled steroids on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1635-1639
13. Pavord ID, Pizzichini MM, Pizzichini E, et al. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52:498-501
14. Barczyk A, Pierzchala W, Sozanska E. Levels of CC-chemokines (MCP-1, MIP-1α, MIP-1β) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis. Pneumonol Alergol Pol 2001; 69:40-49
15. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51:267-271
16. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277-1285
17. Fujimoto K, Kubo K, Yamamoto H, et al. Eosinphilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest 1999; 115:697-702
18. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356:1480-1485
19. Reid DW, Ward C, Wang N, et al. Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo. Eur Respir J 2003; 21:994-999
20. Lopuhaa CE, Out TA, Jansen HM, et al. Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma. Clin Exp Allergy 2002; 32:1720-1727
21. Gupta S, Feng L, Yoshimura T, et al. Intra-alveolar macrophage- inflammatory peptide 2 induces rapid neutrophil localization in the lung. Am J Respir Cell Mol Biol 1996; 15:656-663
22. Morozov VI, Pryatkin SA, Kalinski MI, et al. Effect of exercise to exhaustion on myeloperoxidase and lysozyme release from blood neutrophils. Eur J Appl Physiol 2003; 89:257-262
23. Asti C, Ruggieri V, Porzio S, et al. Lipopolysaccharide-induced lung injury in mice: I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage. Pulm Pharmacol Ther 2000; 13:61-69
24. Aoki K, Ishida Y, Kikuta N, et al. Role of CXC chemokines in the enhancement of LPS-induced neutrophil accumulation in the lung of mice by dexamethasone. Biochem Biophys Res Commun 2002; 294:1101-1108
25. Lefort J, Singer M, Leduc D, et al. Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-α formation and neutrophil sequestration into the murine lungs. J Immunol 1998; 161:474-480
26. Jaovisidha P, Peeples ME, Brees AA, et al. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol 1999; 163:2816-2820